ASD Healthcare is now AmerisourceBergen specialty distribution
As part of the next phase of our evolution, the ASD Healthcare brand will be streamlined as AmerisourceBergen’s specialty distribution capabilities. This change does not impact ordering or contracting.

Oncology

Product Catalog

/

Oncology

Showing 1 to 50 of 267 entries
Category Product Name ABC # Size NDC # Manufacturer
Oncology Lenvima® 10245099 20 mg cap 30 UD 62856-0720-30 Eisai
Oncology Lonsurf® 10245019 15 mg/40 tabs 64842-1025-02 Taiho Oncology
Oncology Ninlaro® 10251102 3 mg caps 3/pk 63020-0079-02 Millennium Rx-Ninlaro
Oncology Ninlaro® 10251212 4 mg caps 3/pk 63020-0080-02 Millennium Rx-Ninlaro
Oncology Nplate® 10248169 125 mcg SDV 0.25 mL 55513-0223-01 Amgen
Oncology Portrazza® 10244998 800 mg /50 mL SDV SOL 00002-7716-01 Eli Lilly & Co
Oncology Promacta® 10242529 12.5 mg tab 30 00078-0684-15 Novartis
Oncology Promacta® 10240112 25 mg tab 30 00078-0685-15 Novartis
Oncology Promacta® 10252020 12.5 mg PWD 00078-0972-61 Novartis
Oncology Promacta® 10248979 25 mg PWD 00078-0697-61 Novartis
Oncology Promacta® 10240438 50 mg tab 30 00078-0686-15 Novartis
Oncology Promacta® 10240108 75 mg tab 30 00078-0687-15 Novartis
Oncology Provenge® 10251231 250 mL 30237-8900-06 Dendreon Pharmaceuticals
Oncology Rituxan® 10245307 100 mg/10 mL 50242-0051-21 Genentech
Oncology Rituxan® 10246682 500 mg/50 mL 50242-0053-06 Genentech
Oncology Rituxan® Hycela 10244524 1600 mg SDV 50242-0109-01 Genentech
Oncology Rituxan® Hycela 10245088 1400 mg SDV 50242-0108-01 Genentech
Oncology Rozlytrek™ 10245334 100 mg/30 caps 50242-0091-30 Genentech
Oncology Rozlytrek™ 10246143 200 mg/90 caps 50242-0094-90 Genentech
Oncology Rubraca® 10245138 200 mg/60 tabs 69660-0201-91 Clovis Oncology
Oncology Rubraca® 10245518 250 mg/60 tabs 69660-0202-91 Clovis Oncology
Oncology Rubraca® 10249152 300 mg/60 tabs 69660-0203-91 Clovis Oncology
Oncology Sarclisa® 10246453 100 mg/5 mL 00024-0654-01 Genzyme
Oncology Somatuline® Depot 10244237 120 mg PFS 15054-1120-04 Ipsen Pharmaceuticals
Oncology Stivarga® 10244989 40 mg tabs 50419-0171-03 Bayer
Oncology Sustol® 10248815 10 mg/0.4 mL PFS kit 6/pk 47426-0101-06 Heron Therapeutics
Oncology Sutent® 10248919 12.5 mg/28 caps 00069-0550-38 Pfizer
Oncology Sutent® 10246459 25 mg/28 caps 00069-0770-38 Pfizer
Oncology Sutent® 10245663 37.5 mg/28 caps 00069-0830-38 Pfizer
Oncology Sutent® 10246849 50 mg/28 caps 00069-0980-38 Pfizer
Oncology Tafinlar® 10242019 50 mg/120 caps 00078-0682-66 Novartis
Oncology Tafinlar® 10243649 75 mg/120 caps 00078-0681-66 Novartis
Oncology Tagrisso® 10244957 40 mg/30 tabs 00310-1349-30 AstraZeneca
Oncology Tagrisso® 10246862 80 mg/30 tabs 00310-1350-30 AstraZeneca
Oncology Talzenna® 10247166 0.25 mg/30 caps 00069-0296-30 Pfizer
Oncology Talzenna® 10247257 1 mg/30 caps 00069-1195-30 Pfizer
Oncology Targretin® 10244412 1% gel 60 gm 00187-5525-60 Valeant Pharmaceuticals
Oncology Targretin® 10245413 75 mg SGC 100 00187-5526-75 Valeant Pharmaceuticals
Oncology Tasigna® 10241762 200 mg/28 caps 00078-0526-87 Novartis
Oncology Tasigna® 10238996 150 mg/28 caps 00078-0592-87 Novartis
Oncology Tasigna® 10243362 50 mg/120 caps 00078-0951-66 Novartis
Oncology Tazverik™ 10248176 200 mg/240 tabs 72607-0100-00 Epizyme
Oncology Tecentriq® 10244254 840 mg/14 mL SDV 50242-0918-01 Genentech
Oncology Venclexta® 10248153 100 mg/180 tabs 00074-0576-34 Abbvie
Oncology Venclexta® 10246882 Starter Pack 00074-0579-28 Abbvie
Oncology Vidaza® 10247065 100 mg 59572-0102-01 Celgene Corporation
Oncology Vitrakvi® 10245813 25 mg cap 60 71777-0390-01 Bayer
Oncology Vitrakvi® 10248913 100 mg cap 60 50419-0391-01 Bayer
Oncology Zaltrap® 10245583 100 mg/4 mL SDV SOL 00024-5840-01 Genzyme
Oncology Zaltrap® 10248515 200 mg/8 mL SDV SOL 00024-5841-01 Genzyme
Showing 1 to 50 of 267 entries
Previous123456Next
Showing 1 to 50 of 267 entries
Previous123456Next
Live Chat
Click to Start
Offline